Cybin
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cybin and other ETFs, options, and stocks.About CYBN
Cybin, Inc. operates as a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. It is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds.
CEODouglas L. Drysdale
CEODouglas L. Drysdale
Employees50
Employees50
HeadquartersToronto, Ontario
HeadquartersToronto, Ontario
Founded2016
Founded2016
Employees50
Employees50
CYBN Key Statistics
Market cap139.60M
Market cap139.60M
Price-Earnings ratio-1.36
Price-Earnings ratio-1.36
Dividend yield—
Dividend yield—
Average volume573.65K
Average volume573.65K
High today$6.69
High today$6.69
Low today$5.81
Low today$5.81
Open price$6.58
Open price$6.58
Volume1.21M
Volume1.21M
52 Week high$13.88
52 Week high$13.88
52 Week low$4.81
52 Week low$4.81
Analyst ratings
100%
of 7 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own CYBN. This list is generated using Robinhood data, and it’s not a recommendation.